Dreyfus Andrew has filed 6 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 10958 shares of Alto Neuroscience, Inc. ($ANRO) on May 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | Alto Neuroscience, Inc. | $ANRO | Dreyfus Andrew | Director | A | Stock Option (right to buy) | 10958 | $0.00 | 10,958.0000 | 31,066,335 | 9999.99% | 0.04% |
| June 10, 2025 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Dreyfus Andrew | Not found | A | Class A Common Stock | 45000 | $0.00 | 228,313.0000 | 160,974,000 | 24.55% | 0.03% |
| May 13, 2025 | Alto Neuroscience, Inc. | $ANRO | Dreyfus Andrew | Director | A | Stock Option (right to buy) | 15287 | $0.00 | 15,287.0000 | 27,072,129 | 9999.99% | 0.06% |
| June 18, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Dreyfus Andrew | Not found | A | Class A Common Stock | 24311 | $0.00 | 188,230.0000 | 157,700,000 | 14.83% | 0.02% |
| Feb. 1, 2024 | Alto Neuroscience, Inc. | $ANRO | Dreyfus Andrew | Not found | A | Stock Option (right to buy) | 30574 | $0.00 | 30,574.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Dreyfus Andrew | Director | A | Class A Common Stock | 22350 | $0.00 | 168,980.0000 | 186,680,000 | 15.24% | 0.01% |